Celldex Therapeutics (CLDX) Reports In-Line Q2 EPS
Get Alerts CLDX Hot Sheet
Join SI Premium – FREE
Celldex Therapeutics (NASDAQ: CLDX) reported Q2 EPS of ($0.32), in-line with the analyst estimate of ($0.32). Revenue for the quarter came in at $592 thousand versus the consensus estimate of $340 thousand.
For earnings history and earnings-related data on Celldex Therapeutics (CLDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Torrid Holdings Inc. (CURV) Tops Q4 EPS by 4c, provides guidance
- Planet Labs (PL) Reports In-Line Q4 EPS, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!